JPMORGAN CHASE & CO - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 4 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2022$56,000
-99.2%
12,000
-90.7%
0.00%
-100.0%
Q2 2020$6,634,000
+101.5%
129,300
+53.9%
0.00%0.0%
Q2 2018$3,292,000
+11.1%
84,000
+86.7%
0.00%0.0%
Q4 2017$2,963,00045,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 709,500$4,512,0000.01%
SIMPLEX TRADING, LLC 426,100$2,709,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JANE STREET GROUP, LLC 113,600$722,0000.00%
View complete list of ESPERION THERAPEUTICS INC NE shareholders